Research and Markets: US Therapeutic Drug Monitoring (TDM) Market 2014 …Business Wire (press release)… Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Q…
Steroid dose increase after CRS unnecessary to prevent hypotensionClinical AdvisorPatients having major colorectal surgery while receiving steroid treatment are routinely given high-dose corticosteroids to prevent acute perioperative adrenal insufficie…
Exceptional response to everolimus is reported in patient with bladder cancer …Oncology Nurse AdvisorA patient with advanced bladder cancer experienced a complete response to the drug combination everolimus and pazopanib in a phase 1 clinical trial. …
India.Com HealthHyperventilation — causes, symptoms, treatment and preventionIndia.Com HealthQuick relief medicines such as short-acting inhaled bronchodilators or oral corticosteroids. Hospital stay in case of severe asthma where you will be given br…
|
The yellow superfood you never knew was super
NEWS.com.au (blog) In fact, in numerous studies, curcumin’s anti-inflammatory effects have been shown to be comparable to the potent drugs hydrocortisone and phenylbutazone as well as over-the-counter anti-inflammatory agents such as ibuprofen.” Being antioxidant rich. |
Phase 3 study of sirolimus for posterior segment uveitis achieves primary endpointHealioSanten Inc. announced that its first of two global phase 3 studies analyzing the efficacy and safety of intravitreal injections of sirolimus in noninfectious poster…
Drug Discovery & Development |
Curis, Debiopharm Report Anti-Tumor Activity, Synergy with Debio 0932
Drug Discovery & Development Debio 0932 is currently being investigated in a Phase 1/2 trial in combination with SOC agents in patients with advanced NSCLC and in a Phase 1 trial in combination with everolimus, an mTOR inhibitor, in advanced RCC patients. In a high throughput … Curis and Debiopharm Group Report Preclinical Data for Debio 0932 at AACR …PR Newswire (press release) Curis and Debiopharm Group(TM) Report Preclinical Data for Debio 0932 at …Wall Street Journal |
Hindu Business LineNPPA caps prices of 17 formulation-based drugsHindu Business LineThe NPPA has fixed an upper cap on 17 formulation-based bulk drugs including Ciprofloxacin hydrochloride, Sulfasalazine, Promethazine, Prednisolone, Metronidazaloe, Pro…
Curis, Debiopharm Group Reports Debio 0932 Demonstrated Anti-Tumor ActivityBenzingaAdditionally, Debio 0932 also showed strong synergy with everolimus in multiple patient derived and conventional RCC cell lines. Similar synergy and anti-tumor activity …
Curis and Debiopharm Group(TM) Report Preclinical Data for Debio 0932 at …Wall Street JournalAdditionally, Debio 0932 also showed strong synergy with everolimus in multiple patient derived and conventional RCC cell lines. Similar synergy and anti-tum…